XAIR - Beyond Air® To Participate in the Truist Securities BioPharma Symposium | Benzinga
GARDEN CITY, N.Y., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ:XAIR) ("Beyond Air" or the "Company") a commercial stage medical device and biopharmaceutical company focused on harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders and solid tumors (through its affiliate Beyond Cancer, Ltd. ("Beyond Cancer")), today announced that Steve Lisi, Chairman and Chief Executive Officer of Beyond Air, will provide a corporate presentation and participate in one-on-one meetings at the Truist Securities BioPharma Symposium being held on Wednesday, November 8, 2023 in New York, NY.
| Truist Securities BioPharma Symposium |
| Title: |
| Beyond Air (NASDAQ:XAIR) Company Presentation |
| Date: |
| Wednesday, November 8th |
| Participants: |
| Steve Lisi, Chairman & CEO, Beyond Air |
If you are ...